Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 50 minutes agoAstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021.
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 6 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine ...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 6 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 7 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 9 hours agoWhat's After Covid Shots? Investors are paying close attention to the bespoke cancer vaccine in...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...